Compare Manulife Financial Corporation (MFC) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manulife Financial Corporation vs Otis Worldwide Corp — how do they compare? Manulife Financial Corporation trades at $43.58 (market cap $69.26B), while Otis Worldwide Corp trades at $66.12 (market cap $25.03B). The key difference: Manulife Financial Corporation is far larger — about 2.8× Otis Worldwide Corp's market cap, and Manulife Financial Corporation pays the higher dividend (3.27%). Which is the better fit depends on your goals — on Pluang, investors hold Manulife Financial Corporation for 119 Days and Otis Worldwide Corp for 65 Days on average.
| MFC | OTIS | |
|---|---|---|
Market Cap | $69.26B | $25.03B |
Volume | 1,347,387 | 2,974,901 |
Sector | Financials | Industrials |
52-Week High | $44.77 | $93.62 |
52-Week Low | $31.64 | $64.05 |
Typical Hold Time | 119 Days | 65 Days |
Enterprise Value | $64.51B | $33.06B |
Dividend Yield | 3.27% | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Manulife Financial (MFC) trades at $41.67, down 2.94% with bearish technical signals despite strong fundamentals. The company reported solid Q2 2026 earnings of $0.79 per share, beating expectations, with revenue growth to $53.01 billion in 2025 and improving cash flow trends. Recent institutional investments from Bank of America and executive appointments signal confidence in long-term strategy.
MFC presents a mixed outlook with strong profitability metrics (11.7% net margin, 13.88% ROE) and analyst consensus favoring Buy ratings (57%), but faces technical headwinds and premium valuation concerns. The stock trades above the $34.24 consensus target, suggesting limited near-term upside despite operational strength and dividend stability.
Otis Worldwide trades at $66.11, down 0.51% on the day and near its 52-week low. The stock shows bearish technical signals with mixed analyst sentiment (46.7% buy, 46.7% hold). Recent earnings have missed expectations for three consecutive quarters, though the company maintains stable revenue around $14.4 billion and strong service-based cash flows. CEO succession plans for 2027 and margin pressures in China remain key focus areas.
The investment outlook balances Otis's market leadership in elevator services against near-term headwinds. Upside potential exists if service margins recover and China demand stabilizes, supported by a consensus price target of $87.00. However, risks include persistent cost pressures, weak equipment demand, and high debt levels with a debt-to-asset ratio of 75.54% in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manulife Financial Corporation
Manulife provides life insurance and wealth management products and services to individuals and group customers in Canada, the United States, and Asia. Manulife is one of Canada's Big Three Life Insurance companies (the other two are Sun Life and Great West Life). As of Dec. 31, 2021, Manulife reported assets under management or administration of about CAD $1.4 trillion.
Read more on MFC →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
